This phenomenon of multiple different subclonal somatic events contributing to the biallelic inactivation of a tumor suppressor gene has not been previously described in other tumor predisposition syndromes to the best of our knowledge, and the clinical implications of this intriguing observation about the origins of NF1-associated gliomas remains to be defined. This evidence concerns the gene NF1 and BAP1-related tumor predisposition syndrome.